TMAO Testing: A New Way To Assess Heart Attack And Stroke Risk

Cleveland HeartLab biomarkers, heart attack and stroke, TMAO

A new blood test that measures levels of TMAO (trimethylamine-N-oxide) — a metabolite derived from gut bacteria — can powerfully predict future risk for heart attack, stroke, and death in patients who appear otherwise healthy, according to pioneering Cleveland Clinic research. The new test — now available through Cleveland HeartLab — measures blood levels of TMAO, a compound produced by more »